Basf Se Corporation

Basf Aktiengesellschaft

The Clorox Company

Michael Schönherr

Karl Kolter

Hermann Ascherl

Kathrin Meyer-Böhm

Angelika Maschke

Jochem Henkelmann

William L Smith

Eckhard Stroefer

Clement K Choy

Wilhelm Ruppel

Thomas Subkowski

Dieter Baumann

Alfred G Zielske

Ulrike Wegerle

Birgit Potthoff-Karl

Hans Rupert Merkle

Stefan Blei

David A Peterson

Matthias Rauls

Thomas Heidenfelder

Silke Gebert

Felicitas Guth

Thomas W Kaaret

Lafayette D Foland

James E Deline

Michael J Petrin

Sebastian Koltzenburg

Holger Türk

Andreas Wölfert

Erich Fretschner

Kevin A Klotter

Martin Karches

Marvin Karos

Heinrich-Josef Blankertz

William P Sibert

Michael Becker

Cedric Dieleman

Karl Siegfried Brenner

Thomas Letzelter

Franz Weber

Tillmann Faust

Torsten Knieriem

Susan P Huestis

Martin J Phillippi

Carsten Knösche

Frank Mrzena

Christian Benz

Ulrich Brockel

Michael Klemens Müller

Francois Becker

Sarah A Perkins

Anne Van Gastel

Victor M Casella

Matthias Klötzer

Bianca Stäck

Marcus Wichtner

Jan-Peter Mittwollen

Tillman Faust

Ulrike Richter

Hans Peter Seelmann-Eggebert

Ulrich Menge

Pharmaceutical formulation in the form of agglomerates comprising

Pharmaceutical formulation for the production of rapidly disintegrating tablets

Described is a storage-stable dust-free homogeneous particulate formulation. The formulation consists of (a) at least one water-soluble Vitamin E-derivative, (b) at least one hydrophilic polymer, (c) optionally additional surface-active substances, and (d) optionally additional pharmaceutical additives. The sum of (a), (b), (c) and (d) equals 100% by weight of the formulation. The fines fraction with particle diameters of less than 100 &#x3bc;m is less than 10% by weight. Describe also is a process for manufacturing the formulation, and use of the formulation as a solubilizing composition in pharmaceutical formulations.

Storage-stable dust-free homogeneous particulate formulation

A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble Vitamin E-derivative and at least one hydrophilic polymer. In one embodiment the storage-stable dust-free homogeneous particle formulation, consists of Methods of making the particulate formulation by a spray granulation process are also provided.

Storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin E-derivative and at least one hydrophilic polymer

The present invention relates to a method for the production of solid solutions of sparingly soluble pesticides, pulverulent products that are obtained by said method and their use for pesticide formulations.

Production of solid solutions of pesticides by short-term superheating and rapid drying

The present invention comprises a process for purifying isocyanate-comprising residues.

Method for purifying residues containing isocyanates

The present patent application describes a method of regenerating a ruthenium catalyst for the hydrogenation of benzene, which comprises flushing the catalyst with inert gas in a regeneration step until the original activity or part of the original activity has been attained.

Method of regenerating ruthenium catalysts for the hydrogenation of benzene

Pharmaceutical formulation in the form of agglomerates comprising A) an excipient content composed of 

Pharmaceutical formulation in the form of compacts comprising

A pharmaceutical formulation in the form of agglomerates comprising

Pharmaceutical formulation for producing rapidly disintegrating tablets

Method for the production of dry, free-flowing, stable hydrophobin preparations by spraying and drying aqueous hydrophobin solutions, if appropriate comprising additives in a spray device.

Method for the production of dry free-flowing hydrophobin preparations

A crystalline solid which has a sufficiently low hygroscopicity for processing and use and essentially consists of glycine-N,N-diacetic acid derivatives is prepared by adjusting the water content of the starting material containing the glycine-N,N-diacetic acid derivatives to a value of from 10 to 30% by weight, based on the starting material, and subsequently bringing about crystallization.

Preparation of a crystalline solid from glycine-N,N-diacetic acid

Process for preparing solid, free-flowing water-soluble salts of

Granules are provided that are useful for oxidizing applications when the granules are dissolved in the presence of an active oxygen source. These granules include a salt having the structure of Formula I ##STR1## wherein A is a saturated ring formed by a plurality of atoms in addition to the N.sub.1 atom, the saturated ring atoms including at least one carbon atom and at least one of O, S, and N atoms, the substituent R.sub.1 bound to the N.sub.1 atom of the Formula I structure including either (a) a C.sub.1-24 alkyl or alkoxylated alkyl where the alkoxy is C.sub.2-4, (b) a C.sub.4-24 cycloalkyl, (c) a C.sub.7-24 alkaryl, (d) a repeating or nonrepeating alkoxy or alkoxylated alcohol, where the alkoxy unit is C.sub.2-4, or (e) --CR.sub.2 R.sub.3 C.tbd.N where R.sub.2 and R.sub.3 are each H, a C.sub.1-24 alkyl, cycloalkyl, or alkaryl, or a repeating or nonrepeating alkoxyl or alkoxylated alcohol where the alkoxy unit is C.sub.2-4, the R.sub.2 and R.sub.3 substituents being each H, a C.sub.1-24 alkyl, cycloalkyl, or alkaryl, or a repeating or nonrepeating alkoxyl or alkoxylated alcohol where the alkoxy unit is C.sub.2-4, Z is in the range of 0 to 10, and wherein Y is a counterion. The salt is carried by, coated with, or admixed with a solid particulate such as silica gel, silicic acid, silicate, aluminum oxide, clay, aluminum silicate, or mixtures thereof.

Granular N-alkyl ammonium acetontrile compositions

Growing community of inventors

Frankenthal, Germany

Michael Schönherr